ITTO20020674A1 - Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico - Google Patents
Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceuticoInfo
- Publication number
- ITTO20020674A1 ITTO20020674A1 IT2002TO000674A ITTO20020674A ITTO20020674A1 IT TO20020674 A1 ITTO20020674 A1 IT TO20020674A1 IT 2002TO000674 A IT2002TO000674 A IT 2002TO000674A IT TO20020674 A ITTO20020674 A IT TO20020674A IT TO20020674 A1 ITTO20020674 A1 IT TO20020674A1
- Authority
- IT
- Italy
- Prior art keywords
- sub
- chosen
- group
- cck
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002TO000674A ITTO20020674A1 (it) | 2002-07-26 | 2002-07-26 | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
| US10/523,075 US7294648B2 (en) | 2002-07-26 | 2003-07-23 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| EP03766505A EP1532105B1 (en) | 2002-07-26 | 2003-07-23 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| ES03766505T ES2325496T3 (es) | 2002-07-26 | 2003-07-23 | Derivados de antranilo que tienen una actividad anticolecistoquinina (anti-cck-1), un proceso para su preparacion, y uso farmaceutico de ellos. |
| PCT/IB2003/002922 WO2004013087A1 (en) | 2002-07-26 | 2003-07-23 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| AT03766505T ATE433439T1 (de) | 2002-07-26 | 2003-07-23 | Anthranyl-derivate mit anti-cholecystokinin- aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung |
| PT03766505T PT1532105E (pt) | 2002-07-26 | 2003-07-23 | Derivados de antracilo possuindo uma actividade anticolecistoquinina (anti-cck-1), um processo para a sua preparação e sua utilização farmacêutica |
| DE60327932T DE60327932D1 (de) | 2002-07-26 | 2003-07-23 | Anthranyl-derivate mit anti-cholecystokinin-aktivität (anti-cck-1) verfahren zu deren herstellung und deren pharmazeutische anwendung |
| AU2003253114A AU2003253114B8 (en) | 2002-07-26 | 2003-07-23 | Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| CA2493789A CA2493789C (en) | 2002-07-26 | 2003-07-23 | Anthranyl derivatives having an anti cholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| JP2004525597A JP4530853B2 (ja) | 2002-07-26 | 2003-07-23 | 抗コレシストキニン活性（抗−ｃｃｋ−１）を有するアントラニル酸誘導体、その製造法および医薬用途 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2002TO000674A ITTO20020674A1 (it) | 2002-07-26 | 2002-07-26 | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ITTO20020674A0 ITTO20020674A0 (it) | 2002-07-26 |
| ITTO20020674A1 true ITTO20020674A1 (it) | 2004-01-26 |
Family
ID=11459544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT2002TO000674A ITTO20020674A1 (it) | 2002-07-26 | 2002-07-26 | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7294648B2 (it) |
| EP (1) | EP1532105B1 (it) |
| JP (1) | JP4530853B2 (it) |
| AT (1) | ATE433439T1 (it) |
| AU (1) | AU2003253114B8 (it) |
| CA (1) | CA2493789C (it) |
| DE (1) | DE60327932D1 (it) |
| ES (1) | ES2325496T3 (it) |
| IT (1) | ITTO20020674A1 (it) |
| PT (1) | PT1532105E (it) |
| WO (1) | WO2004013087A1 (it) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ542491A (en) | 2003-03-28 | 2009-04-30 | Janssen Pharmaceutica Nv | Benzo[1,2,5]thiadiazole compounds as CCK2 modulators |
| EP1651621B1 (en) | 2003-08-08 | 2008-08-06 | Janssen Pharmaceutica N.V. | 2- (quinoxalin-5-ylsulfonylamino) -benzamide compounds as cck2 modulators |
| CA2581426A1 (en) | 2004-09-24 | 2006-04-06 | Janssen Pharmaceutica, N.V. | Sulfonamide compounds |
-
2002
- 2002-07-26 IT IT2002TO000674A patent/ITTO20020674A1/it unknown
-
2003
- 2003-07-23 ES ES03766505T patent/ES2325496T3/es not_active Expired - Lifetime
- 2003-07-23 PT PT03766505T patent/PT1532105E/pt unknown
- 2003-07-23 CA CA2493789A patent/CA2493789C/en not_active Expired - Fee Related
- 2003-07-23 AT AT03766505T patent/ATE433439T1/de not_active IP Right Cessation
- 2003-07-23 JP JP2004525597A patent/JP4530853B2/ja not_active Expired - Fee Related
- 2003-07-23 WO PCT/IB2003/002922 patent/WO2004013087A1/en active Application Filing
- 2003-07-23 DE DE60327932T patent/DE60327932D1/de not_active Expired - Lifetime
- 2003-07-23 AU AU2003253114A patent/AU2003253114B8/en not_active Ceased
- 2003-07-23 US US10/523,075 patent/US7294648B2/en not_active Expired - Fee Related
- 2003-07-23 EP EP03766505A patent/EP1532105B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005533866A (ja) | 2005-11-10 |
| US20060111304A1 (en) | 2006-05-25 |
| ATE433439T1 (de) | 2009-06-15 |
| PT1532105E (pt) | 2009-06-29 |
| CA2493789A1 (en) | 2004-02-12 |
| CA2493789C (en) | 2012-05-01 |
| DE60327932D1 (de) | 2009-07-23 |
| JP4530853B2 (ja) | 2010-08-25 |
| EP1532105B1 (en) | 2009-06-10 |
| WO2004013087A1 (en) | 2004-02-12 |
| AU2003253114A1 (en) | 2004-02-23 |
| AU2003253114B2 (en) | 2009-07-16 |
| ES2325496T3 (es) | 2009-09-07 |
| AU2003253114B8 (en) | 2009-08-13 |
| EP1532105A1 (en) | 2005-05-25 |
| US7294648B2 (en) | 2007-11-13 |
| ITTO20020674A0 (it) | 2002-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0413232B8 (pt) | composto tendo atividade inibitória contra transportador dependente de sódio, composição farmacêutica compreendendo o composto, uso do composto na preparação de um medicamento e processo para a preparação do composto | |
| DK0628311T3 (da) | Xanthinderivater som antidepressive midler | |
| ES2194314T3 (es) | Derivados de benzopirano sustituidos para el tratamiento de inflamaciones. | |
| ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
| NO20014928L (no) | Farmasöytiske forbindelser | |
| UY28623A1 (es) | Derivados de pirazol y usos de los mismos | |
| DE602004012758D1 (de) | Chinoxalinderivate als inhibitoren der neutrophilelastase und deren verwendung | |
| MXPA04001240A (es) | Analogos antitumorales. | |
| DK1643984T3 (da) | Anvendelse af parthenolidderivater som antileukæmiske og cytotoksske midler | |
| BR0107770A (pt) | Derivados de 3-fenóxi-1-fenil acetileno e seu uso como herbicidas | |
| DK1320526T3 (da) | Farmaceutisk aktive benzsulfonamidderivater som inhibitorer af protein-junkinaser | |
| ATE266664T1 (de) | Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DK1204662T3 (da) | Azaindoler med serotoninreceptoraffinitet | |
| FI870347A (fi) | Nya dihydrobensofuran- och kromankarboxiamidderivat, foerfarande foer deras framstaellning och deras anvaendning som neuroleptiska medel. | |
| PT790248E (pt) | Derivados de 3-aza-piperidona-(tetra-hidropirimidin-2-ona) e 3-oxa-piperidona(1,3 oxazin-2-ona) sua preparacao e uso como antagonistas de taquicinina/neurocinina | |
| AR035110A1 (es) | Compuesto derivado de piperazina, uso del mismo para la preparacion de una composicion farmaceutica, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto | |
| BRPI0210746B8 (pt) | derivados de 6-'2-(fosfonometóxi)alcóxi-pirimidina e seu método de preparação | |
| ITTO20020674A1 (it) | Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico | |
| AR028743A1 (es) | DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA | |
| DE50101861D1 (de) | Tocotrienolchinon- zyklisierungsprodukte mit antihypercholesterin wirkung | |
| DK1086071T3 (da) | Hyperforinforbindelser, anvendelse heraf og formuleringer indeholdende disse | |
| MX9405111A (es) | Nuevos derivados de (1-fenil-1-heterociclil)metanol y(1-fenil-1-heterociclil-metilamina). | |
| AR027454A1 (es) | Derivados de beta-alanina, utiles como antagonistas de receptores, las composiciones farmaceuticas que las contienen y el uso de los mismos para lapreparacion de medicamentos | |
| AR045600A1 (es) | Tienoimidazoles sustituidos, procedimiento para su preparacion, su uso como un medicamento o adyuvante de diagnostico y medicamento que los comprende | |
| DE69702955T2 (de) | Bis-Imide Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitung |